Complete Metabolic Response — What It Means on a PET Scan
A complete metabolic response is the best possible result a PET scan can report. It means the scanner found no detectable abnormal metabolic activity where cancer was previously seen. It is important news — and it comes with limits your oncologist will explain.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
- Best possible PET result — No detectable metabolic activity in areas where cancer was previously seen.
- Not the same as cure — CMR describes what the scanner can see. It does not mean every cancer cell is gone.
- Timing changes the meaning — A CMR midway through treatment carries different weight than one taken after treatment ends.
- Follow-up continues — Your team will plan scans and appointments to monitor the response over time.
on Panel
Survival Rate*
Treated
(800+ reviews)
A complete metabolic response (CMR) means a PET scan found no detectable areas of abnormal metabolic activity where cancer was previously visible. It is the best possible result on a PET report. It does not confirm that every cancer cell has been eliminated, and your oncologist will use it alongside other information to plan what happens next.
What do the terms on your PET report mean?
- Complete metabolic response (CMR)
- The scanner found no area of abnormal metabolic activity that can be attributed to cancer. It is the highest category of response recorded on a PET report. The phrase 'no evidence of metabolic activity' means the same thing.
- Metabolic activity
- PET scans track how cells absorb a radioactive sugar called FDG. Cancer cells often absorb more than normal cells do. 'Metabolic activity' on a report refers to areas where that uptake is higher than the expected background level.
- Standardised uptake value (SUV)
- A number the scanner assigns to each area of uptake. Higher values indicate greater metabolic activity. Your report may list an SUVmax figure. Whether a particular value is clinically significant depends on the cancer type, the timing of the scan, and what your team is comparing it against.
- Deauville score
- A five-point scale used to assess PET results in lymphoma, where lower scores indicate less residual metabolic activity. The Lugano classification — endorsed by ESMO and used by most lymphoma teams — maps specific score ranges to CMR or to partial response. Ask your oncologist what score you received and what it means for your plan.
- Partial metabolic response (PMR)
- The scan shows reduced metabolic activity compared with the last scan, but some activity remains. This means the treatment has had an effect, but not a complete one. It is the response category below CMR.
What should you do now that you have this result?
- Bring the printed report to your next oncology appointment, even if your team already has it on their system.
- Ask your oncologist to explain what this result means specifically for your cancer type and the point you are at in treatment.
- Ask when the next scan or assessment is planned and what it will be looking for.
- Ask which symptoms or changes to report between now and the next appointment.
- If another doctor is involved in your care — a GP or another specialist — let them know a response assessment has been done.
- Do not adjust any medication, supplement, or diet based on this result alone. Discuss any change with your oncologist first.
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
How does CMR compare to the other PET response categories?
| CMR | PMR | SMD | PMD | |
|---|---|---|---|---|
| What the scan shows | No detectable abnormal metabolic activity in prior cancer areas | Reduced activity — some remains | Activity unchanged from the previous scan | Increased activity or new areas of uptake |
| What the term describes | No cancer measurable by the scanner | Partial response to treatment | No measurable response to treatment | Cancer not responding — or progressing |
| What your team will typically discuss | Follow-up scan schedule and monitoring plan | Continuing, adjusting, or intensifying treatment | Reviewing whether the current treatment plan should change | Urgent review of available options |
Did you know?
In Hodgkin lymphoma, ESMO guidance recognises that a complete metabolic response on an interim PET scan — taken after two cycles of treatment — is used to decide whether the remaining chemotherapy should be intensified or reduced.
The same CMR result carries a different clinical meaning depending on when in the treatment course the scan is taken.
Source: ESMO Clinical Practice Guidelines: Hodgkin Lymphoma
Book a PET-CT at CION from Rs 10,499 — among the lowest published prices in Hyderabad — with an oncologist-reviewed report and a free Rs 950 consultation, across 4 partner centres. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Frequently asked questions
Does complete metabolic response mean I am cured?
A CMR means the scanner found no detectable metabolic activity where cancer was previously visible. It does not confirm that every cancer cell has been eliminated, because a PET scan has a detection limit — very small numbers of cells or tiny clusters may be below what the scanner can see. 'No evidence of disease on PET' and 'cured' are different statements. Your oncologist will explain what this result means for your specific cancer type, including how durable this kind of response tends to be.
What happens after a complete metabolic response?
Follow-up is planned by your oncologist and depends on your cancer type, your treatment, and when in treatment the scan was taken. For most people this means scheduled clinical appointments and, in many cases, further scans at intervals your team will specify. The aim is to detect any change early. Ask your oncologist the exact follow-up plan for your situation, including how long monitoring continues and what symptoms to report between appointments.
Can cancer come back after a complete metabolic response?
Yes, it can, and being direct about this is more useful than a reassurance that is not guaranteed. A CMR is the best possible PET result, and for many cancer types it is associated with better outcomes — but it is not a guarantee of permanent remission. This is why follow-up continues after a CMR rather than stopping. If cancer does return, it is often detectable at an early stage through the monitoring your team has planned.
What is the difference between CMR and CR (complete response)?
CMR refers specifically to the PET scan finding — no measurable metabolic activity. CR, or complete response, is a broader oncology term for the disappearance of all measurable signs of cancer, often assessed by CT scan using criteria such as RECIST. Some response frameworks use both measurements together. Your report may use either term, and your oncologist can explain which assessment method was applied and what the result means in your case.
Why does the report say CMR but my doctor still seems cautious?
A CMR is good news, and a cautious response from your oncologist is not a contradiction. Several things can explain it: some cancer types relapse even after a CMR; the result may be from an interim scan rather than an end-of-treatment one; or there may be other findings in the report that need monitoring. Your oncologist has more information than any single PET finding. Ask them directly what they are watching for, so you understand the reason behind the follow-up plan.
What is an interim PET, and does CMR on it mean the same as CMR at the end of treatment?
An interim PET is taken during treatment — often to check how cancer is responding before the full course is complete. A CMR on an interim scan means no detectable activity at that point. ESMO and ASCO guidance uses interim PET CMR results to guide decisions about continuing, adapting, or changing treatment in several cancer types. An end-of-treatment CMR answers a different question: whether the full course has eliminated detectable disease. Ask your oncologist which type of scan you had and what the result means in that specific context.